Effects of topical antifibrinolytics in endoscopic sinus surgery: A pilot randomized controlled trial

American Journal of Rhinology

Volumn 21, Issue 6, 2007, Pages 737-742

  Athanasiadis, Theodore ^a   Beule, Achim G ^a,b   Wormald, Peter J ^a,c  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b UNIVERSITY OF GREIFSWALD   (Germany)

^c QUEEN ELIZABETH HOSPITAL   (Australia)

Author keywords

Amicar; Aminocaproic acid; Cyklokapron; Endoscopic sinus surgery; Hemostasis; Surgical grade; Topical antifibrinolytics; Tranexamic acid

Indexed keywords

AMINOCAPROIC ACID; ANTIFIBRINOLYTIC AGENT; PLACEBO; TRANEXAMIC ACID;

ARTICLE; BLEEDING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; ENDOSCOPIC SURGERY; HUMAN; NOSE SURGERY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

6-AMINOCAPROIC ACID; ADULT; AGED; ANTIFIBRINOLYTIC AGENTS; BLOOD LOSS, SURGICAL; DOUBLE-BLIND METHOD; ENDOSCOPY; FEMALE; HEMOSTASIS, SURGICAL; HUMANS; MALE; MIDDLE AGED; NIMODIPINE; PARANASAL SINUS DISEASES; PILOT PROJECTS; TRANEXAMIC ACID;

EID: 38349014635     PISSN: 10506586     EISSN: None     Source Type: Journal    
DOI: 10.2500/ajr.2007.21.3097     Document Type: Article

References (38)

1. Wormald P-J, Athanasiadis T, Rees G, and Robinson S. An evaluation of effect of pterygopalatine fossa injection with local anesthetic and adrenalin in the control of nasal bleeding during endoscopic sinus surgery. Am J Rhinol 19:288-292, 2005.
2. Wormald P-J. The surgical field in endoscopic sinus surgery. In Endoscopic Sinus Surgery-Anatomy, Three-Dimensional Reconstruction, and Surgical Technique. New York: Thieme, 2005. 7-12.
3. Riegle EV GJ, Lusk RP, et al. Comparison of vasoconstrictors for functional endoscopic sinus surgery in children. Laryngoscope 102:820-823, 1992.
4. Gleich LL, Rebeiz EE, Pankratov MM, and Shapshay SM. Autologous fibrin tissue adhesive in endoscopic sinus surgery. Otolaryngol Head Neck Surg 112:238-241, 1995.
5. Shaw C-KL, Dymock R, Cowin A, and Wormald P-J. Effect of packing on nasal mucosa of sheep. J Laryngol Otol 114: 506-509, 2000.
6. Maccabee MS, Trune DR, and Hwang PH. Effects of topically applied biomaterials on paranasal sinus mucosal healing. Am J Rhinol 17:203-207, 2003.
7. Davey AK, and Maher PJ. Surgical adhesions: A timely update, a great challenge for the future. J Minim Invasive Gynecol 14:15-22, 2007.
8. Chandra RK, Conley DB, and Kern RC. The effect of FloSeal on mucosal healing after endoscopic sinus surgery: A comparison with thrombin-soaked gelatin foam. Am J Rhinol 17:51-55, 2003.
9. Chandra RK, Conley DB, Haines GK III, and Kern RC. Long-term effects of FloSeal packing after endoscopic sinus surgery. Am J Rhinol 19:240-243, 2005.
10. Chandra RK, and Kern RC. Advantages and disadvantages of topical packing in endoscopic sinus surgery. Curr Opin Otolaryngol Head Neck Surg 12:21-26, 2004.
11. Okamoto S, and Sato SYT. An active stereo isomer (transform) of AMCHA and its fibrinolytic (antiplasminic) action in vitro and in vivo. Keio J Med 13:177-185, 1964.
12. Wellington K, and Wagstaff AJ. Tranexamic acid - A review of its use in the management of menorrhagia. Drugs 63: 1417-1433, 2003.
13. Dunn C, and Goa K. Tranexamic acid - A review of its use in surgery and other indications. Drugs 57:1005-1032, 1999.
14. Manucci PM. Drug therapy: Hemostatic drugs. N Engl J Med 339:245-253, 1998.
15. Mannucci PM. Treatment of von Willebrand's disease. N Engl J Med 351:683-694, 2004.
16. Aroney R, Dalley D, and Levi J. Haemorrhagic cystitis treated with epsilon-aminocaproic acid. Med J Aust 2:92, 1980.
17. Tenholder M, and Cushner FD. Intraoperative blood management in joint replacement surgery. Orthopedics 27:S663-S668, 2004.
18. Zufferey P, Merquiol F, Laporte S, et al. Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery? Anesthesiology 105:1034-1046, 2006.
19. Lemay E, Guay J, Cote C, and Roy A. Tranexamic acid reduces the need for allogenic red blood cell transfusions in patients undergoing total hip replacement. Can J Anaesth 51:31-37, 2004.
20. Molenaar I, Warnaar N, Groen H, et al. Efficacy and safety of antifibrinolytic drugs in liver transplantation: A systematic review and meta-analysis. Am J Transplant 7:185-194, 2007.
21. Brown RS, Thwaites BK, and Mongan PD. Tranexamic acid is effective in decreasing postoperative bleeding and transfusions in primary coronary artery bypass operations: A double-blind, randomized, placebo-controlled trial. Anesth Analg 85:963-970, 1997.
22. Shpilberg O, Blumenthal R, Sofer O, et al. A controlled trial of tranexamic acid therapy for the reduction of bleeding during treatment of acute myeloid leukemia. Leuk Lymphoma 19:141-144, 1995.
23. Baric D, Biocina B, Unic D, et al. Topical use of antifibrinolytic agents reduces postoperative bleeding: A double-blind, prospective, randomized study. Eur J Cardithorac Surg 2007. In press.
24. Athanasiadis T, Beule AG, Embate J, et al. Standardized video-endoscopy and surgical field grading scale for endoscopic sinus surgery: A multi-centre study. Laryngoscope (in press).
25. De Bonis M, Cavaliere F, Alessandrini F, et al. Topical use of tranexamic acid in coronary artery bypass operations: A double-blind, prospective, randomized, placebo-controlled study. J Thorac Cardiovasc Surg 119:575-580, 2000.
26. Krohn C, Sorensen R, Lange J, et al. Tranexamic acid given into the wound reduces postoperative blood loss by half in major orthopaedics surgery. Eur J Surg Suppl 588:57-61, 2003.
27. Crouch ER, Williams PB, Gray MK, et al. Topical aminocaproic acid in the treatment of traumatic hyphema. Arch Opthalmol 115:1106-1112, 1997.
28. Pieramici DJ, Goldberg MF, Melia M, et al. A phase III, multicenter, randomized, placebo-controlled clinical trial of topical aminocaproic acid (Caprogel) in the management of traumatic hyphema. Ophthalmology 110:2106-2112, 2003.
29. Carter G, and Goss A. Tranexamic acid mouthwash - A prospective randomized study of a 2-day regimen vs 5-day regimen to prevent postoperative bleeding in anticoagulated patients requiring dental extractions. Int J Oral Maxillofac Surg 32:504-507, 2003.
30. Sindet-Pedersen S, Ramstrom G, Bernvil S, and Blomback M. Haemostatic effect of tranexamic acid mouthwash in anticoagulant-treated patients undergoing oral surgery. N Engl J Med 320:840-843, 1989.
31. Klepfish A, Berrebi A, and Schattner A. Intranasal tranexamic acid treatment for severe epistaxis in hereditary hemorrhagic telangiectasia. Arch Int Med 161:767, 2001.
32. Saba HI, Morelli G, and Logrono L. Brief report: Treatment of bleeding in hereditary hemorrhagic telangiectasia with aminocaproic acid. N Engl J Med 330:1789-1790, 1994.
33. Sabba C, Gallitelli M, and Palasciano G. Efficacy of unusually high doses of tranexamic acid for the treatment of epistaxis in hereditary hemorrhagic telangiectasia. N Engl J Med 345:926, 2001.
34. Boezaart A, van der Merwe J, and Coetzee A. Comparison of sodium nitroprusside-and esmolol-induced controlled hypotension for functional endoscopic sinus surgery. Can J Anaesth 42:373-376, 1995.
35. Yaniv E, Shvero J, and Hadar T. Hemostatic effect of tranexamic acid in elective nasal surgery. Am J Rhinol 20:227-229, 2006.
36. Henry DA, Moxey AJ, Carless PA, et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev CD001886, 2001.
37. Dubber A, GP M, and Douglas A. Some properties of the antifibrinolytically active isomer of amino-methyl-cyclohexane carboxylic acid. Lancet 11:1317-1319, 1964.
38. Sindet-Pedersen S. Distribution of tranexamic acid to plasma and saliva after oral administration and mouth rinsing: A pharmacokinetic study. J Clin Pharmacol 27:1005-1008,1987.